Skip to content

Clinical trials

Phase 3 Obesity trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Phase 3 Country / region: Denmark Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20081
20111
20131
20183
20214
20221
20233
20258
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting13
Completed12
Active, not recruiting6
Terminated3
Not yet recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S21
Eli Lilly and Company4
Amgen3
Sanofi3
Boehringer Ingelheim2
AstraZeneca1
Bjorn H. Ebdrup1
Nordsjaellands Hospital1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity37
Overweight15
Nutrition Disorders3
Diabetes Mellitus, Type 12
Diabetes Mellitus, Type 22
Heart Failure2
Osteoarthritis, Knee2
Atherosclerosis1
Body Weight1
Cardiovascular Diseases1

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.